1
Lugner, A.K., van Boven, Michiel, de Vries, Robin, Postma, M.J., Wallinga, J.
Veröffentlicht in: Lugner , A K , van Boven , M , de Vries , R , Postma , M J & Wallinga , J 2012 , ' Cost effectiveness of vaccination against pandemic influenza in European countries : mathematical modelling analysis ' , British Medical Journal , vol. 345 , 4445 . https://doi.org/10.1136/bmj.e4445;
2012
Veröffentlicht in: Lugner , A K , van Boven , M , de Vries , R , Postma , M J & Wallinga , J 2012 , ' Cost effectiveness of vaccination against pandemic influenza in European countries : mathematical modelling analysis ' , British Medical Journal , vol. 345 , 4445 . https://doi.org/10.1136/bmj.e4445;
2012
2
Bos, J.M., Rietveld, E., Moll, HA, Steyerberg, E.W., Luytjes, W., Wilschut, J.C., de Groot, R., Postma, M.J.
Veröffentlicht in: Bos , J M , Rietveld , E , Moll , HA , Steyerberg , E W , Luytjes , W , Wilschut , J C , de Groot , R & Postma , M J 2007 , ' The use of health economics to guide drug development decisions : Determining optimal values for an RSV-vaccine in a model-based scenario-analytic approach ' , Vaccine , vol. 25 , no. 39-40 , pp. 6922-6929 . https://doi.org/10.1016/j.vaccine.2007.07.006;
2007
Veröffentlicht in: Bos , J M , Rietveld , E , Moll , HA , Steyerberg , E W , Luytjes , W , Wilschut , J C , de Groot , R & Postma , M J 2007 , ' The use of health economics to guide drug development decisions : Determining optimal values for an RSV-vaccine in a model-based scenario-analytic approach ' , Vaccine , vol. 25 , no. 39-40 , pp. 6922-6929 . https://doi.org/10.1016/j.vaccine.2007.07.006;
2007
3
Rozenbaum, M.H., Sanders, E.A.M., van Hoek, A.J., Jansen, A.G.S.C., van der Ende, A., van den Dobbelsteen, G., Rodenburg, G.D., Hak, E., Postma, M.J.
Veröffentlicht in: Rozenbaum , M H , Sanders , E A M , van Hoek , A J , Jansen , A G S C , van der Ende , A , van den Dobbelsteen , G , Rodenburg , G D , Hak , E & Postma , M J 2010 , ' Cost effectiveness of pneumococcal vaccination among Dutch infants : an economic analysis of the seven valent pneumococcal conjugated vaccine and forecast for the 10 valent and 13 valent vaccines ' , British Medical Journal , vol. 340 , 2509 , pp. Art. No. c2509- . https://doi.org/10.1136/bmj.c2509;
2010
Veröffentlicht in: Rozenbaum , M H , Sanders , E A M , van Hoek , A J , Jansen , A G S C , van der Ende , A , van den Dobbelsteen , G , Rodenburg , G D , Hak , E & Postma , M J 2010 , ' Cost effectiveness of pneumococcal vaccination among Dutch infants : an economic analysis of the seven valent pneumococcal conjugated vaccine and forecast for the 10 valent and 13 valent vaccines ' , British Medical Journal , vol. 340 , 2509 , pp. Art. No. c2509- . https://doi.org/10.1136/bmj.c2509;
2010